Beaconcure Inc. is a biotechnology and software company that develops AI-enabled clinical trial data solutions. The company was founded in 2016 and is based in Tel Aviv, Israel, with an office in Boston, United States.
Subscribe to see Beaconcure’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Beaconcure is a healthtech company headquartered in Israel, founded in 2015. Its most recent funding round raised $15M in January 2025. Xcout tracks 12 named people at Beaconcure, including Seth Houston (Chief Executive Officer).
6 more named people on record for Beaconcure, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $15M | — | |
| Series B | $14M | 4 named | |
| SEC Form D filing | $9.9M | — | |
| SEC Form D filing | $2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Beaconcure's closest competitors — see the full list of competitors and alternatives →
Curebase, Inc. is a San Francisco-based company founded in 2017 that provides eClinical software solutions. Its platform streamlines clinical trials and enhances data management for biotechnology and healthcare organizations.
QMENTA is an all-in-one governed imaging platform built by neuroscientists to manage clinical trial data and run artificial intelligence workflows. Headquartered in Boston, Massachusetts, the company helps remove delays from imaging stages in medical research.
Clinical Research IO (CRIO) provides an intuitive eSource software platform designed to streamline clinical trials and clinical research operations. Headquartered in Boston, Massachusetts, the company serves research sites and healthcare organizations.
Faro Health develops software for designing and optimizing clinical trial protocols. It serves biopharmaceutical and clinical research organizations by helping teams assess trial feasibility, cost, timelines, and patient burden.
Triomics, Inc. is a U.S. healthcare technology company that uses artificial intelligence and natural-language processing to structure oncology data from clinical records and genomic reports. Its platform serves cancer centers, oncologists, and life-sciences organizations by supporting precision-oncology workflows such as clinical-trial matching and patient identification.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.